163015
Thallium(III) nitrate trihydrate
Synonym(s):
TTN, Thallium trinitrate
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Linear Formula:
Tl(NO3)3 · 3H2O
CAS Number:
Molecular Weight:
444.44
NACRES:
NA.22
PubChem Substance ID:
UNSPSC Code:
12161600
EC Number:
237-325-4
MDL number:
Quality Level
reaction suitability
core: thallium, reagent type: catalyst
mp
102-105 °C (lit.)
SMILES string
O.O.O.[Tl+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O
InChI
1S/3NO3.3H2O.Tl/c3*2-1(3)4;;;;/h;;;3*1H2;/q3*-1;;;;+3
InChI key
ZCPIKMRXMBJLCP-UHFFFAOYSA-N
Application
Reagent for the rapid oxidation of styrene derivatives to carbonyl compounds, for the regioselective ring expansion of cyclic aralkyl ketones via oxidative rearrangement, for the selective hydrolysis of thioacetals to carbonyl compounds and for a general synthetic method to 19-norsteroids. Mediates ring contraction of cyclic ketones to a series of trans-fused 10-methyl-2-decalones.
signalword
Danger
hcodes
Hazard Classifications
Acute Tox. 2 Inhalation - Acute Tox. 2 Oral - Aquatic Chronic 2 - STOT RE 2
Storage Class
5.1B - Oxidizing hazardous materials
flash_point_f
Not applicable
flash_point_c
Not applicable
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Articles
Oxidation and reduction reactions are some of the most common transformations encountered in organic synthesis
Tetrahedron Letters, 1827-1827 (1977)
Lamis Yehia et al.
NPJ genomic medicine, 2, 37-37 (2017-12-22)
Bannayan-Riley-Ruvalcaba syndrome (BRRS) is a rare congenital disorder classically characterized by macrocephaly in combination with intestinal hamartomatous polyposis, vascular malformations, lipomas, and genital lentiginosis. Germline
Marta Gigli et al.
Journal of the American College of Cardiology, 74(11), 1480-1490 (2019-09-14)
Genotype-phenotype correlations in dilated cardiomyopathy (DCM) and, in particular, the effects of gene variants on clinical outcomes remain poorly understood. The purpose of this study was to investigate the prognostic role of genetic variant carrier status in a large cohort